CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways

Chemico-Biological Interactions

Volumn 183, Issue 1, 2010, Pages 187-193

  Bocca, C ^a   Bozzo, F ^a   Cannito, S ^a   Colombatto, S ^a   Miglietta, A ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Catenin E cadherin; CLA; ER ; MCF 7; MDA MB 231; PI3K Akt

Indexed keywords

CONJUGATED LINOLEIC ACID; ESTROGEN RECEPTOR ALPHA; GELATINASE A; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN P85;

ARTICLE; BREAST CANCER; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL STRAIN MCF 7; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LINOLEIC ACIDS, CONJUGATED; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 71349088463     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.09.022     Document Type: Article

References (41)

1. Kelly G.S. Conjugated linoleic acid: a review. Altern. Med. Rev. 6 (2001) 367-382
2. Kelley N.S., Hubbard N.E., and Erickson K.L. Conjugated linoleic acid isomers and cancer. J. Nutr. 137 (2007) 2599-2607
3. Adams L.S., Phung S., Wu X., Ki L., and Chen S. White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice. Nutr. Cancer 60 (2008) 744-756
4. Belury M.A. Dietary conjugated linoleic acid in health-physiological effects and mechanisms of action. Annu. Rev. Nutr. 22 (2002) 505-531
5. Maggiora M., Bologna M., Cerù M.P., Possati L., Angelucci A., Cimini A., Miglietta A., Bozzo F., Margiotta C., Muzio G., and Canuto R.A. An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int. J. Cancer 112 (2004) 909-919
6. Kim E.J., Kang I.J., Cho H.J., Kim W.K., Ha Y.L., and Park J.H. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J. Nutr. 133 (2003) 2675-2681
7. Bocca C., Bozzo F., Gabriel L., and Miglietta A. Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J. Nutr. Biochem. 18 (2007) 332-340
8. Chujo H., Yamasaki M., Nou S., Koyanagi N., Tachibana H., and Yamada K. Effect of conjugated linoleic acid isomers on growth factor-induced proliferation of human breast cancer cells. Cancer Lett. 202 (2003) 81-87
9. Kim J.H., Hubbard N.E., Ziboh V., and Erickson K.L. Attenuation of breast tumor cell growth by conjugated linoleic acid via inhibition of 5-lipoxygenase activating protein. Biochim. Biophys. Acta 736 (2005) 244-250
10. Evans M., Brown J., and McIntosh M. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J. Nutr. Biochem. 13 (2002) 508-516
11. Bhattacharya A., Banu J., Rahman M., Causey J., and Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J. Nutr. Biochem. 17 (2006) 789-810
12. Sauer L.A. Dietary factors and growth and metabolism in experimental tumors. J. Nutr. Biochem. 18 (2007) 637-649
13. Liu J.R., Li B.X., Chen B.Q., Han Y.M., Xue Y.B., Yang Y.M., Zheng R.H., and Liu R.H. Effect of cis-9, trans-11-conjugated linoleic acid on cell cycle of gastric adenocarcinoma cell line (SGC-7901). World J. Gastroenterol. 8 (2002) 224-229
14. Cho H.J., Kim W.K., Jung J.I., Kim E.J., Lim S.S., Kwon D.Y., and Park J.H. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J. Gastroenterol. 11 (2005) 5142-5150
15. Carnero A., Blanco-Aparicio C., Renner O., Link W., and Leal J.F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8 (2008) 187-198
16. Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A., Fusco A., and Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8 (2002) 1136-1144
17. Lin C.F., Chen C.L., Chiang C.W., Jan M.S., Huang W.C., and Lin Y.S. GSK-3β acts downstream of PP2A and the PI3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. J. Cell Sci. 120 (2007) 2935-2943
18. Kerr F., Rickle A., Nayeem N., Brandner S., Cowburn R.F., and Lovestone S. PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Lett. 580 (2006) 3121-3128
19. Ivaska J., Nissinen L., Immonen N., Eriksson J.E., Kähäri V.M., and Heino J. Integrin alpha 2β 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta. Mol. Cell. Biol. 22 (2002) 1352-1359
20. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
21. Huang H., and He X. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol. 20 (2008) 119-125
22. Akiyama T., and Kawasaki Y. Wnt signalling and the actin cytoskeleton. Oncogene 25 (2006) 7538-7544
23. Kolligs F.T., Kolligs B., Hajra K.M., Hu G., Tani M., Cho K.R., and Fearon E.R. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev. 14 (2000) 1319-1331
24. Simcha I., Geiger B., Yehuda-Levenberg S., Salomon D., and Ben-Ze'ev A. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J. Cell Biol. 133 (1996) 199-209
25. Yoeli-Lerner M., Chin Y.R., Hansen C.K., and Toker A. Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor. Mol. Cancer Res. 7 (2009) 425-432
26. Miglietta A., Bozzo F., Gabriel L., Bocca C., and Canuto R.A. Extracellular signal-regulated kinase 1/2 and protein phosphatase 2A are involved in the antiproliferative activity of conjugated linoleic acid in MCF-7 cells. Br. J. Nutr. 96 (2006) 22-27
27. Miglietta A., Bozzo F., Bocca C., Gabriel L., Trombetta A., Belotti S., and Canuto R.A. Conjugated linoleic acid induces apoptosis in MDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett. 234 (2006) 149-157
28. Bocca C., Bozzo F., Francica S., Colombatto S., and Miglietta A. Involvement of PPAR gamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int. J. Cancer 121 (2007) 248-256
29. Palombo J.D., Ganguly A., Bistrian B.R., and Menard M.P. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett. 177 (2002) 163-172
30. Ip C., Chin S.F., Scimeca J.A., and Pariza M.W. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 51 (1991) 6118-6124
31. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14 (2002) 381-395
32. Petridou A., Mougios V., and Sagredos A. Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids 38 (2003) 805-811
33. Andrabi S., Gjoerup O.V., Kean J.A., Roberts T.M., and Schaffhausen B. Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 19011-19016
34. Seeling J.M., Miller J.R., Gil R., Moon R.T., White R., and Virshup D.M. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283 (1999) 2089-2091
35. Prasad C.P., Gupta S.D., Rath G., and Ralhan R. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology 73 (2007) 112-117
36. Bozzo F., Bocca C., Colombatto S., and Miglietta A. Antiproliferative effect of conjugated linoleic acid in caco-2 cells: involvement of PPARgamma and APC/beta-catenin pathways. Chem. Biol. Interact. 169 (2007) 110-121
37. Rosette C., Roth R.B., Oeth P., Braun A., Kammerer S., Ekblom J., and Denissenko M.F. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26 (2005) 943-950
38. Yuan Z., Wong S., Borrelli A., and Chung M.A. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem. Biophys. Res. Commun. 362 (2007) 740-746
39. Arnold S.F., Obourn J.D., Jaffe H., and Notides A.C. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II, consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 55 (1995) 163-172
40. Lu Q., Surks H.K., Ebling H., Baur W.E., Brown D., Pallas D.C., and Karas R.H. Regulation of estrogen receptor alpha-mediated transcription by a direct interaction with protein phosphatase 2A. J. Biol. Chem. 278 (2003) 4639-4645
41. Denton R.R., Koszewski N.J., and Notides A.C. Estrogen receptor phosphorylation: hormonal dependence and consequence on specific DNA binding. J. Biol. Chem. 267 (1992) 7263-7268